Cerebral Ischemia Clinical Trial
Official title:
A Pilot Trial to Assess the Feasibility and Efficacy of Treating Post-Cardiac Surgery Cerebral Desaturation in the Intensive Care Unit
Study objectives: The main objective of this study is to determine the feasibility of
implementing measures in the intensive care unit (ICU), based on a physiological algorithm,
to reverse decreases in cerebral oxygen saturation using, near-infrared spectroscopy (NIRS).
Methods: Randomization of 50 patients is balanced by experimental group; control and
intervention, with an allocation sequence based on a block size of ten, generated with a
computer random number generator. In the intervention group ICU Staff will use NIRS to follow
a physiologically guided strategy to maintain regional oxygen saturation (rSO2) within 90% of
baseline values. In the control group ICU Staff will provide standard of care without the use
of NIRS.
Background and Rationale: Cerebral desaturation has previously been shown to be associated
with significant morbidity in cardiac surgery postoperatively. As such, previously reported
efforts have been aimed at treating intraoperative desaturation events, with early evidence
suggesting that this may reduce the incidence of these adverse events. Our previous study,
NIRS ICU (B2011:110) has demonstrated that significant cerebral oxygen desaturation [measured
using near infrared spectroscopy (NIRS) derived cerebral oximetry] frequently occurs in the
intensive care unit (ICU) within the first 24 hours following cardiac surgery. To date, no
studies have addressed the early postoperative period (i.e. in the ICU) with respect to
treating (and/or preventing) these desaturation events.
Specific Aims and Experimental Design: The specific aim of this pilot prospective
interventional trial is to determine the feasibility/efficacy of treating cerebral oxygen
desaturation in the ICU following cardiac surgery. Two groups of patients will be studied.
Both groups will have cerebral saturation measured continuously both intraoperatively and
postoperatively. The control group however, will have these measurements blinded to the
intraoperative and postoperative caregivers. The interventional group will have the cerebral
oximetry measurements available to the intraoperative and postoperative care team allowing
them to intervene when a desaturation event occurs. If a cerebral desaturation occurs,
defined as a decline in saturation of 10% from the patient's preoperative baseline, then a
previously utilized interventional algorithm, normal cerebral oxygen saturation (NORMOSAT)
(B2012:005), will be instituted to reverse the decrease in cerebral saturation, ideally
preventing it from becoming a clinically meaningful desaturation (previously defined by
others as saturation decline of 25% from the baseline). The algorithm used addresses many of
the known causes of desaturation, including low arterial oxygen content (both saturation and
hemoglobin) and cardiac output influences on cerebral blood flow. As such, if a desaturation
occurs, the patient will first have the partial pressure of oxygen (PaO2) increased by
increasing the inspired oxygen content. The partial pressure of carbon dioxide (PaCO2) will
also be normalized by adjusting the ventilator settings. The cardiac output will be optimized
and the blood pressure will be increased with standard ICU protocols to administer
phenylephrine. If remaining low, the patients will be transfused to standard of care
hemoglobin levels.
In this pilot trial, a convenience sample of 50 consecutive consenting patients undergoing
cardiac surgery employing cardiopulmonary bypass (CPB) will be studied. After obtaining
consent, bilateral cerebral oximetry sensors will be placed on the forehead of patients prior
to the induction of anesthesia. Baseline (breathing room air) regional cerebral saturation
will be recorded. Following this, induction of anesthesia will occur and continuous NIRS
measurements will be collected during the surgical procedure with continued monitoring
occurring for the first 24 hours (or until discharge) within the ICU. In the control group,
conventional anesthesia and ICU standards of care will be carried out throughout the study
period. In the interventional group, an algorithm based on the modification of previously
defined important physiologic variables will be initiated to reverse the desaturation
(beginning when the saturation drops at least 10% from the baseline) that occurs in the
operating room (OR) and ICU.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT04167527 -
Endovascular Therapy for Low NIHSS Ischemic Strokes
|
Phase 2/Phase 3 | |
Recruiting |
NCT04583163 -
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
|
||
Completed |
NCT01436812 -
Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy
|
N/A | |
Terminated |
NCT00141011 -
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
|
Phase 3 | |
Recruiting |
NCT05053932 -
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
|
||
Completed |
NCT04437862 -
A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT00598819 -
A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00207961 -
The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia
|
N/A | |
Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
Completed |
NCT02351518 -
Cerebral Autoregulation and Vasospasm in Patients With TBI
|
||
Completed |
NCT01546636 -
The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position
|
N/A | |
Completed |
NCT04047563 -
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
|
Phase 3 | |
Completed |
NCT05087836 -
Correlation of Cerebral Oxygen Saturation Measured From 2 Sensor Sites: Forehead vs. Temporal
|
||
Completed |
NCT02448069 -
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
|
Phase 2 | |
Completed |
NCT02147275 -
Monitoring Hypertensive Patients's Cerebral Oxygen Saturation
|
N/A | |
Completed |
NCT02389647 -
Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury
|
||
Completed |
NCT02643030 -
Hypercapnia During Shoulder Arthroscopy
|
N/A | |
Completed |
NCT01436799 -
Desflurane Versus Propofol in the Sitting Position
|
N/A | |
Terminated |
NCT01312623 -
Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease
|
N/A |